本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Monte Rosa Therapeutics

12.32
+1.1810.59%
盘前12.330.0100+0.08%08:51 EDT
成交量:215.04万
成交额:2,577.57万
市值:7.61亿
市盈率:41.88
高:12.44
开:11.30
低:11.26
收:11.14
52周最高:12.44
52周最低:3.50
股本:6,175.94万
流通股本:3,030.34万
量比:2.56
换手率:7.10%
股息:- -
股息率:- -
每股收益(TTM):0.2942
每股收益(LYR):-0.9836
净资产收益率:9.81%
总资产收益率:2.66%
市净率:2.84
市盈率(LYR):-12.53

数据加载中...

2024/08/12

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/12

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/30

重要事件披露

Form 8-K - Current report
2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]